FDA Approved: CABENUVA — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA has approved a supplemental application for CABENUVA (cabotegravir and rilpivirine) submitted by ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• CABENUVA (cabotegravir and rilpivirine)

Snippet

SUPPL AP for CABENUVA (CABOTEGRAVIR AND RILPIVIRINE)